ImmunologybioRxiv
Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis
D. L. E. Vergoossen, J. J. Plomp, C. Gstottner…·M. G. Huijbers
This study shows that monovalent anti-MuSK IgG4 antibodies enhance pathogenicity in myasthenia gravis compared to their bivalent form.
DOI 10.1073/pnas.2020635118